Captrust Financial Advisors Royalty Pharma PLC Transaction History
Captrust Financial Advisors
- $33 Billion
- Q3 2024
A detailed history of Captrust Financial Advisors transactions in Royalty Pharma PLC stock. As of the latest transaction made, Captrust Financial Advisors holds 29,328 shares of RPRX stock, worth $948,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,328
Previous 30,924
5.16%
Holding current value
$948,467
Previous $815,000
1.72%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
423Shares Held
286MCall Options Held
577KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.33 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$744 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$457 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$393 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...